Total Payments
$19,786
2024 Payments
$3,226
Companies
54
Transactions
870
Medicare Patients
9,088
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$19,459 (98.3%)
Other$203.30 (1.0%)
Education$123.58 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,459 | 854 | 98.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $203.30 | 11 | 1.0% |
| Education | $123.58 | 5 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $1,570 | 43 | $0 (2024) |
| Amgen Inc. | $1,414 | 58 | $0 (2023) |
| Neurelis, Inc. | $1,282 | 42 | $0 (2024) |
| ABBVIE INC. | $1,217 | 57 | $0 (2024) |
| Arbor Pharmaceuticals, Inc. | $1,009 | 58 | $0 (2022) |
| UCB, Inc. | $1,004 | 78 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $885.84 | 34 | $0 (2022) |
| Allergan, Inc. | $875.01 | 45 | $0 (2022) |
| Lilly USA, LLC | $870.84 | 40 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $850.93 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,226 | 112 | Otsuka America Pharmaceutical, Inc. ($451.82) |
| 2023 | $3,324 | 131 | Otsuka America Pharmaceutical, Inc. ($399.11) |
| 2022 | $3,221 | 155 | UCB, Inc. ($287.93) |
| 2021 | $3,166 | 160 | AbbVie Inc. ($389.34) |
| 2020 | $1,903 | 93 | Allergan, Inc. ($382.43) |
| 2019 | $1,939 | 84 | EISAI INC. ($471.17) |
| 2018 | $1,957 | 88 | Eisai Inc. ($538.79) |
| 2017 | $1,049 | 47 | Eisai Inc. ($190.52) |
All Payment Transactions
870 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.73 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/06/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Kyowa Kirin, Inc. | Nourianz (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: Adenosine A2A Receptors | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Neurology | ||||||
| 11/14/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Analgesic | ||||||
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $120.41 | General |
| Category: PSYCHIATRY | ||||||
| 11/12/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: EPILEPSY | ||||||
| 11/08/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Neuroscience | ||||||
| 11/05/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Neurology | ||||||
| 11/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: AMANTADINE | ||||||
| 11/01/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $24.73 | General |
| Category: NEUROLOGY | ||||||
| 10/29/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/25/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $5.26 | General |
| Category: Neurology | ||||||
| 10/24/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $33.91 | General |
| Category: EPILEPSY | ||||||
| 10/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Neurology | ||||||
| 10/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/17/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,130 | 3,076 | $455,467 | $332,230 |
| 2022 | 20 | 2,419 | 3,636 | $672,922 | $392,772 |
| 2021 | 20 | 2,459 | 3,926 | $696,787 | $429,824 |
| 2020 | 22 | 2,080 | 3,443 | $572,533 | $341,079 |
Total Patients
9,088
Total Services
14,081
Medicare Billing
$1.5M
Procedure Codes
81
All Medicare Procedures & Services
81 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 331 | 565 | $86,153 | $63,868 | 74.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 303 | 658 | $70,766 | $53,345 | 75.4% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 180 | 186 | $62,130 | $48,154 | 77.5% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Office | 2023 | 80 | 82 | $34,543 | $26,958 | 78.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 137 | 140 | $34,056 | $25,510 | 74.9% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 94 | 101 | $29,518 | $23,124 | 78.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 94 | 198 | $23,085 | $18,078 | 78.3% |
| 92546 | Test for abnormal eye movement using a rotating chair | Office | 2023 | 140 | 142 | $26,713 | $17,282 | 64.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 145 | 145 | $19,730 | $14,478 | 73.4% |
| 92540 | Evaluation and testing for balance with recording | Office | 2023 | 140 | 142 | $23,658 | $14,116 | 59.7% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 18 | 18 | $10,228 | $7,653 | 74.8% |
| 92548 | Test for balance and posture | Office | 2023 | 126 | 127 | $9,666 | $5,523 | 57.1% |
| 92537 | Test to assess balance during warm and cool irrigation in both ears | Office | 2023 | 140 | 142 | $11,269 | $5,174 | 45.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $4,942 | $3,875 | 78.4% |
| 20526 | Injection of carpal tunnel | Office | 2023 | 24 | 32 | $3,417 | $2,578 | 75.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 29 | $2,058 | $1,346 | 65.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 47 | 70 | $1,301 | $917.58 | 70.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 40 | 210 | $2,100 | $179.13 | 8.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 43 | 64 | $132.23 | $70.29 | 53.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 355 | 663 | $110,852 | $75,646 | 68.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 318 | 757 | $92,601 | $61,853 | 66.8% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2022 | 185 | 192 | $75,429 | $51,490 | 68.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 130 | 137 | $77,222 | $32,781 | 42.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 130 | 268 | $41,322 | $26,036 | 63.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 132 | 136 | $40,357 | $26,001 | 64.4% |
About Dr. Sergey Zhivotenko, MD
Dr. Sergey Zhivotenko, MD is a Neurology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154348092.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sergey Zhivotenko, MD has received a total of $19,786 in payments from pharmaceutical and medical device companies, with $3,226 received in 2024. These payments were reported across 870 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($19,459).
As a Medicare-enrolled provider, Zhivotenko has provided services to 9,088 Medicare beneficiaries, totaling 14,081 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 81 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Clinical Neurophysiology
- Location Brooklyn, NY
- Active Since 07/16/2006
- Last Updated 03/28/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154348092
Products in Payments
- Fycompa (Drug) $1,545
- VALTOCO (Drug) $1,282
- Aimovig (Biological) $1,279
- Horizant (Drug) $1,136
- NUEDEXTA (Drug) $1,116
- Briviact (Drug) $971.60
- RYTARY (Drug) $778.72
- UBRELVY (Drug) $767.61
- NUPLAZID (Drug) $672.85
- QULIPTA (Drug) $576.20
- EMGALITY (Drug) $537.57
- REXULTI (Drug) $487.06
- INGREZZA (Drug) $446.85
- Auvelity (Drug) $435.35
- Dhivy (Drug) $409.88
- BOTOX (Biological) $409.26
- Gocovri (Drug) $355.36
- GOCOVRI (Drug) $280.51
- Ongentys (Drug) $266.06
- NURTEC ODT (Drug) $265.46
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Brooklyn
Karen Blitz-Shabbir, Do, DO
Neurology — Payments: $393,441
Neurology $393,441
Miss. Larisa Syrow, Md, MD
Neurology — Payments: $182,526
Neurology $182,526
Nada Abou-Fayssal, Md, MD
Neurology — Payments: $126,065
Neurology $126,065
Robyn Wolintz, Md, MD
Neurology — Payments: $123,772
Neurology $123,772
Miran Salgado, Md, MD
Neurology — Payments: $101,072
Neurology $101,072
Dr. Dmitriy Grinshpun, M.d, M.D
Neurology — Payments: $96,680
Neurology $96,680